PHARMACEUTICAL COMPOSITION CONTAINING 8-[(3R)-3-AMINO-1-PIPERIDINYL]-7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-[4-METHYL-2-QUINAZOLINYL)METHYL]-1H-PURINE-2,6-DIONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
The present invention relates to a pharmaceutical composition comprising linagliptin or a pharmaceutically acceptable salt thereof as active ingredient, wherein the pharmaceutical composition does not comprise a binder and wherein the pharmaceutical composition is obtained by direct compression.